Citations

Clear

249 citation(s) found for "St-Denis, L".

Microsurgical Reconstruction of the Plantar Foot: Long-Term Functional Outcomes and Quality of Life
Heidekrueger, Paul I. , Ehrl, Denis , Prantl, Lukas , Aung, Thiha , Weinschenk, Fabian, Forte, Antonio J. , Ninković, Milomir, Broer, P. Niclas, Forte, Antonio Jorge

Mayo Clinic

Journal of Reconstructive Microsurgery | January 18, 2019 | Volume: 35 | Issue: 05 | Pages: 379-388

10.1055/s-0038-1677038 | PMID 30625504 Get It

Background When faced with plantar defects, reconstruction of the weight-bearing areas presents unique surgical challenges. Several free flap modalities have been described in this respect, but there remains debate regarding the best-suited flap modality. Aim of this study was to compare free muscle and non-neurotized fasciocutaneous flaps for plantar reconstruction with respect to long-term functional outcomes. Methods Overall, 89 patients received 100 free flaps (anterolateral thigh [ALT] n = 46; gracilis n = 54) for plantar reconstruction. The data were screened for patients' demographics, as well as perioperative details. Postoperative complications were accounted for and the two groups compared accordingly. All patients were contacted for a long-term follow-up examination. Results There were no significant differences between the two groups regarding major (24 vs. 17%; p = 0.366) and minor surgical complications (61 vs. 70%; p = 0.318). However, the ALT group showed a significantly higher need for secondary surgeries (39 vs. 19%; p = 0.022). Sixty-eight patients (76%) returned for long-term follow-up evaluation (mean: 51.2 months, range: 13–71 months). The ALT group showed significantly less pain at the recipient (p = 0.0004) and donor (p = 0.010) sites, and scar assessment revealed significantly better results (p < 0.001). Additionally, the ALT group showed better depth (p = 0.017) and superficial (p = 0.007) sensation and enabled better shoe provision (p = 0.014). Conclusion Both the free ALT and gracilis flaps are well suited for plantar reconstruction, yielding overall similar functional outcomes. However, the ALT flap produces less scarring and pain, while showing better recovery of sensation and enabling better shoe provision. The ALT flap thus presents our preferred option.
Editorial: a new era in anti-neutrophil cytoplasmic antibody vasculitis
Fouque, Denis , Fervenza, Fernando C.

Mayo Clinic

Nephrology Dialysis Transplantation | January 8, 2019 | Volume: 34 | Issue: 3 | Pages: 379-381

10.1093/ndt/gfz002 | PMID 30834449 Get It

International Expert Consensus on Sutureless and Rapid Deployment Valves in Aortic Valve Replacement Using Minimally Invasive Approaches
Moten, Simon, Quaini, Eugenio, Miceli, Antonio, Oberwalder, Peter, Rambaldini, Manfredo, Teoh, Kevin , Bhatnagar, Gopal , Bouchard, Denis , Bouchot, Olivier , Dapunt, O., Ferrarini, Matteo , Fischlein, Theodor , Millner, Russell, Noirhomme, Philippe, Pfeiffer, Steffen, Ruyra-Baliarda, Xavier, Shrestha, Malakh , Suri, Rakesh M. , Geršak, Borut , Glauber, Mattia , Solinas, Marco , Folliguet, Thierry A , Meuris, Bart , Miceli, Antonio , Borger, Michael A. , Clark, Stephen , Laufer, Günther , Mignosa, Carmelo , Troise, Giovanni

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | January 3, 2019 | Volume: 11 | Issue: 3 | Pages: 165-173

10.1177/155698451601100303 Get It

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction
Schneppenheim, Reinhard , Hellermann, Natalie, Brehm, Maria A. , Klemm, Ulrike, Obser, Tobias, Huck, Volker , Schneider, Stefan W. , Denis, Cécile V. , Tischer, Alexander , Auton, Matthew , Xu, Emma-Ruoqi , Wilmanns, Matthias , Zotz, Rainer B., Xu, Emma-Ruoqi , Wilmanns, Matthias , Auton, Matthew , Tischer, Alexander , März, Winfried

Mayo Clinic

Blood | October 26, 2018 | Volume: 133 | Issue: 4 | Pages: 356-365

10.1182/blood-2018-04-843425 | PMID 30366922 Get It

Abstract The frequent von Willebrand factor (VWF) variant p.Phe2561Tyr is located within the C4 domain, which also harbors the platelet GPIIb/IIIa-binding RGD sequence. To investigate its potential effect on hemostasis, we genotyped 865 patients with coronary artery disease (CAD), 915 with myocardial infarction (MI), and 417 control patients (Ludwigshafen Risk and Cardiovascular Health Study) and performed functional studies of this variant. A univariate analysis of male and female carriers of the Tyr2561 allele aged 55 years or younger revealed an elevated risk for repeated MI (odds ratio, 2.53; 95% confidence interval [CI], 1.07-5.98). The odds ratio was even higher in females aged 55 years or younger, at a value of 5.93 (95% CI, 1.12-31.24). Cone and plate aggregometry showed that compared with Phe2561, Tyr2561 was associated with increased platelet aggregate size both in probands’ blood and with the recombinant variants. Microfluidic assays revealed that the critical shear rate for inducing aggregate formation was decreased to 50% by Tyr2561 compared with Phe2561. Differences in C-domain circular dichroism spectra resulting from Tyr2561 suggest an increased shear sensitivity of VWF as a result of altered association of the C domains that disrupts the normal dimer interface. In summary, our data emphasize the functional effect of the VWF C4 domain for VWF-mediated platelet aggregation in a shear-dependent manner and provide the first evidence that a functional variant of VWF plays a role in arterial thromboembolism.
P4‐065: APOE4 CONDITIONALLY EXPRESSED IN CEREBROVASCULATURE IMPAIRS ENDOTHELIAL FUNCTIONS AND INDUCES COGNITIVE DEFICITS
Kurti, Aishe, Yamazaki, Akari, Fryer, John Denis , Kanekiyo, Takahisa , Yamazaki, Yu , Liu, Chia‐Chen , Oue, Hiroshi , Bu, Guojun

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_27 | Pages: No page available

10.1016/j.jalz.2018.06.2468 Get It

Risk Factors for Persistent Cognitive Impairment After Critical Illness, Nested Case-Control Study
Sakusic, Amra , Gajić, Ognjen, Singh, Tarun D. , O’Horo, John C. , Jenkins, Gregory D. , Wilson, Gregory , Petersen, Ronald C. , Fryer, John Denis , Jenkins, Gregory, Wilson, Gregory A, O'Horo, John C , Gajic, Ognjen , Kashyap, Rahul , Rabinstein, Alejandro A.

Mayo Clinic

Critical Care Medicine | October 2, 2018 | Volume: 46 | Issue: 12 | Pages: 1977-1984

10.1097/ccm.0000000000003395 | PMID 30222636 Get It

Objectives: Persistent cognitive impairment after critical illness is an important healthcare problem forecasted to worsen in the near future. However, the epidemiology is insufficiently explored. We aimed to determine potentially modifiable risk factors during ICU hospitalization that play a significant role in developing persistent cognitive impairment. Design: An observational case-control study. Settings: Mayo Clinic ICUs between July 1, 2004, and November 20, 2015. Patients: We conducted a study nested in a large cohort of 98,227 adult critically ill patients. Using previously validated computable phenotypes for dementia and cognitive impairment, we determined the onset of cognitive impairment relative to ICU hospitalization and associated risk factors. The primary endpoint of the study was new and persistent cognitive impairment documented between 3 and 24 months after ICU discharge. Interventions: Unadjusted and adjusted analyses were performed to identify potentially modifiable risk factors during ICU hospitalization. Measurements and Main Results: Among 21,923 unique patients identified as cognitively impaired (22% of the entire ICU cohort), 2,428 (2.5%) developed incident new and persistent cognitive dysfunction after the index ICU admission. Compared with age- and sex-matched ICU controls (2,401 pairs), cases had higher chronic illness burden (Charlson Comorbidity Index, 6.2 vs 5.1; p < 0.01), and were more likely to have multiple ICU stays (22% vs 14%; p < 0.01). After adjustment for baseline differences, new and persistent cognitive dysfunction was associated with higher frequency of acute brain failure in the ICU, a higher exposure to severe hypotension, hypoxemia, hyperthermia, fluctuations in serum glucose, and treatment with quinolones or vancomycin. Association with sepsis observed in univariate analysis did not persist after adjustment. Conclusions: Cognitive dysfunction is highly prevalent in ICU patients. Incident new and persistent cognitive impairment is less common but important, potentially preventable problem after critical illness. Chronic comorbidities and number of ICU stays increase the risk of post-ICU cognitive dysfunction irrespective of age. Modifiable ICU exposures were identified as potential targets for future prevention trials.
TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO‐OVAR OP7).
Mahner, Sven� , Burges, Alexander , Reuß, Alexander , Kraemer, Bernhard , Schmalfeldt, Barbara, Lampe, Bjoern, Fotopoulou, Christina , Lécuru, Fabrice , Querleu, Denis , Greggi, Stefano , Colombo, Nicoletta , Harter, Philipp , Heitz, Florian , Sehouli, Jalid , Schnelzer, Andreas , Wimberger, Pauline , Guyon, Frédéric , Aletti, Giovanni , Bois, Andreas du

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 35 | Issue: 15_suppl | Pages: TPS5602-TPS5602

10.1200/jco.2017.35.15_suppl.tps5602 Get It

TPS5602 Background: Primary cytoreductive surgery (PDS) followed by chemotherapy has been considered as standard management for advanced ovarian cancer patients (pts) over decades. An alternative approach of interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT) was subsequently reported by two randomized phase III trials (EORTC‐GCG, CHORUS). Owing to important limitations of these studies, especially regarding surgical quality, optimal timing of surgical therapy in advanced ovarian cancer is still unclear. Methods: TRUST is an international open, randomized, controlled multicenter trial investigating overall survival (OS; primary endpoint) after PDS vs NACT and subsequent IDS in pts with FIGO stage IIIB‐IVB ovarian, tubal, and peritoneal carcinoma. Secondary objectives are safety of complete tumor resection, progression‐free survival and quality of life (QoL) as well as surgical morbidity. In order to guarantee adequate surgical quality, participating centers need to fulfill specific quality assurance criteria (e.g. ≥50% complete resection rate in upfront surgery for FIGO IIIB-IV pts, ≥36 debulking-surgeries/year) and agree to independent audits by TRUST Quality committee delegates. A 1:1 randomization to PDS or NACT followed by IDS stratified by center and age‐ECOG combination (ECOG 0 and age ≤65 years vs ECOG > 0 or age > 65 years) is performed. Pts in the PDS arm will undergo surgery followed by 6 cycles of platinum-based chemotherapy, whereas pts in the IDS arm will be treated with 3 cycles of NACT after histologic confirmation of the disease, followed by IDS and subsequently 3 cycles of platinum-based chemotherapy. Intention of surgery for both groups will be complete tumor resection as per guideline recommendations. Health related QoL will be assessed using the EORTC QLQ‐C30, QLQ‐OV28, and EQ‐5D‐3L questionnaires. For sample size planning, we considered a prolongation of median OS from 45 months in the IDS arm to 60 months in the PDS arm (HR 0.75) as clinically relevant. 380 events are needed to obtain a power of 80% in two‐sided log-rank test with significance level of 0.05. The primary analysis will be done in the ITT‐population of 686 randomized pts. By Feb 3 2017, 46 pts were randomized. Clinical trial information: NCT02828618.
Randomized trial comparing a web-mediated follow-up via patient-reported outcomes (PRO) vs. routine surveillance in lung cancer patients: Final results.
Denis, Fabrice , Basch, Ethan , Lethrosne, Claire, Pourel, N. , Molinier, Olivier , Pointreau, Y. , Dômont, Julien , Bourgeois, Hugues , Senellart, Hélène, Urban, T. , Septans, Anne-Lise , Balavoine, Magal, Solal‐Céligny, Philippe , Basch, Ethan , Bennouna, Jaafar , Balavoine, Magali , Dueck, Amylou C. , Letellier, Christophe

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 6500-6500

10.1200/jco.2018.36.15_suppl.6500 Get It

A matter of balance
Fryer, John Denis , Gitler, Aaron D , Fryer, John D , Gitler, Aaron D.

Mayo Clinic

eLife | August 21, 2018 | Volume: 7 | Issue: No issue available | Pages: No page available

10.7554/elife.40034 | PMID 30129439 Get It

New analyses shift the view that some forms of amyotrophic lateral sclerosis and frontotemporal dementia are due to defects in a single RNA-binding protein.
Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau
Kang, Silvia S. , Ebbert, Mark , Baker, Kelsey E., Cook, Casey , Wang, Xuewei , Sens, Jonathon , Kocher, Jeanne-Pierre, Petrucelli, Leonard , Fryer, John Denis , Ebbert, Mark T W , Sens, Jonathon P, Fryer, John D

Mayo Clinic

Journal of Experimental Medicine | August 6, 2018 | Volume: 215 | Issue: 9 | Pages: 2235-2245

10.1084/jem.20180653 | PMID 30082275 Get It

Alzheimer’s disease (AD) is an age-associated neurodegenerative disease characterized by amyloidosis, tauopathy, and activation of microglia, the brain resident innate immune cells. We show that a RiboTag translational profiling approach can bypass biases due to cellular enrichment/cell sorting. Using this approach in models of amyloidosis, tauopathy, and aging, we revealed a common set of alterations and identified a central APOE-driven network that converged on CCL3 and CCL4 across all conditions. Notably, aged females demonstrated a significant exacerbation of many of these shared transcripts in this APOE network, revealing a potential mechanism for increased AD susceptibility in females. This study has broad implications for microglial transcriptomic approaches and provides new insights into microglial pathways associated with different pathological aspects of aging and AD.